| Form 1-K Issuer Information |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-K | OMB APPROVAL |
| OMB Number: 3235-0720 Estimated average burden hours per response: 600.0 |
1-K: Filer Information
| Issuer CIK | 0001620704 |
| Issuer CCC | XXXXXXXX |
| Is filer a shell company? | 
Yes
No
|
| Is the electronic copy of an official filing submitted in paper format? |  |
| File Number | 24R-00024 |
| Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination? |
Yes
No
|
| Successor File Number |
| Is this a LIVE or TEST Filing? |
LIVE
TEST
|
| Would you like a Return Copy? | |
| Period | 12-31-2023 |
| Name | |
| Phone | |
| E-Mail Address |
| Notify via Filing Website only? | |
1-K: Tab 1 Notification
| This Form 1-K is to provide an |
Annual Report
Special Financial Report for the fiscal year
|
| Fiscal Year End | 12-31-2023 |
| Exact name of issuer as specified in the issuer's charter | MED-X, Inc. |
| CIK | 0001620704 |
| Jurisdiction of Incorporation / Organization |
NEVADA
|
| I.R.S. Employer Identification Number | 46-5473113 |
| Address 1 | 8236 Remmet Avenue |
| Address 2 | |
| City | Canoga Park |
| State/Country |
CALIFORNIA
|
| Mailing Zip/ Postal Code | 91304 |
| Phone | 818-349-2870 |
| Title of each class of securities issued pursuant to Regulation A | Common Shares |